News Headline Summary

Mylan Inc (MYL) looses bid to overturn February ruling on Vytorin patents; Merck (MRK) victory will still stand

Reaction details:

- No immediate reaction seen in Merck shares, trades USD 47.33 last. (+1.07%). Similarly, no reaction has been seen in Mylan shares, trades USD 29.10 last. (+1.91%)

Print 15:21, 11 Apr 2013 - US Equities - Source: Newswires